History, progress and future challenges of artificial blood vessels: a narrative review.

Biomaterials Translational Pub Date : 2022-03-28 eCollection Date: 2022-01-01 DOI:10.12336/biomatertransl.2022.01.008
Ke Hu, Yuxuan Li, Zunxiang Ke, Hongjun Yang, Chanjun Lu, Yiqing Li, Yi Guo, Weici Wang
{"title":"History, progress and future challenges of artificial blood vessels: a narrative review.","authors":"Ke Hu,&nbsp;Yuxuan Li,&nbsp;Zunxiang Ke,&nbsp;Hongjun Yang,&nbsp;Chanjun Lu,&nbsp;Yiqing Li,&nbsp;Yi Guo,&nbsp;Weici Wang","doi":"10.12336/biomatertransl.2022.01.008","DOIUrl":null,"url":null,"abstract":"<p><p>Cardiovascular disease serves as the leading cause of death worldwide, with stenosis, occlusion, or severe dysfunction of blood vessels being its pathophysiological mechanism. Vascular replacement is the preferred surgical option for treating obstructed vascular structures. Due to the limited availability of healthy autologous vessels as well as the incidence of postoperative complications, there is an increasing demand for artificial blood vessels. From synthetic to natural, or a mixture of these components, numerous materials have been used to prepare artificial vascular grafts. Although synthetic grafts are more appropriate for use in medium to large-diameter vessels, they fail when replacing small-diameter vessels. Tissue-engineered vascular grafts are very likely to be an ideal alternative to autologous grafts in small-diameter vessels and are worthy of further investigation. However, a multitude of problems remain that must be resolved before they can be used in biomedical applications. Accordingly, this review attempts to describe these problems and provide a discussion of the generation of artificial blood vessels. In addition, we deliberate on current state-of-the-art technologies for creating artificial blood vessels, including advances in materials, fabrication techniques, various methods of surface modification, as well as preclinical and clinical applications. Furthermore, the evaluation of grafts both in vivo and in vitro, mechanical properties, challenges, and directions for further research are also discussed.</p>","PeriodicalId":58820,"journal":{"name":"Biomaterials Translational","volume":"3 1","pages":"81-98"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d8/1c/bt-03-01-81.PMC9255792.pdf","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomaterials Translational","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12336/biomatertransl.2022.01.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Cardiovascular disease serves as the leading cause of death worldwide, with stenosis, occlusion, or severe dysfunction of blood vessels being its pathophysiological mechanism. Vascular replacement is the preferred surgical option for treating obstructed vascular structures. Due to the limited availability of healthy autologous vessels as well as the incidence of postoperative complications, there is an increasing demand for artificial blood vessels. From synthetic to natural, or a mixture of these components, numerous materials have been used to prepare artificial vascular grafts. Although synthetic grafts are more appropriate for use in medium to large-diameter vessels, they fail when replacing small-diameter vessels. Tissue-engineered vascular grafts are very likely to be an ideal alternative to autologous grafts in small-diameter vessels and are worthy of further investigation. However, a multitude of problems remain that must be resolved before they can be used in biomedical applications. Accordingly, this review attempts to describe these problems and provide a discussion of the generation of artificial blood vessels. In addition, we deliberate on current state-of-the-art technologies for creating artificial blood vessels, including advances in materials, fabrication techniques, various methods of surface modification, as well as preclinical and clinical applications. Furthermore, the evaluation of grafts both in vivo and in vitro, mechanical properties, challenges, and directions for further research are also discussed.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人工血管的历史、进展与未来挑战:叙述性回顾。
心血管疾病是世界范围内导致死亡的主要原因,血管狭窄、闭塞或严重功能障碍是其病理生理机制。血管置换术是治疗血管阻塞的首选手术方法。由于健康自体血管的可用性有限以及术后并发症的发生率,对人工血管的需求日益增加。从合成到天然,或这些成分的混合物,许多材料已用于制备人工血管移植物。虽然人造血管更适合用于中、大直径血管,但在替代小直径血管时却失败了。组织工程血管移植物很可能是小直径血管自体移植物的理想替代品,值得进一步研究。然而,在将它们用于生物医学应用之前,仍有许多问题必须解决。因此,本文试图描述这些问题,并对人工血管的产生进行讨论。此外,我们还讨论了目前最先进的人造血管制造技术,包括材料、制造技术、各种表面修饰方法以及临床前和临床应用方面的进展。此外,还讨论了移植物在体内和体外的评价、机械性能、挑战和进一步研究的方向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.70
自引率
0.00%
发文量
9
期刊最新文献
"Yin-Yang philosophy" for the design of anticancer drug delivery nanoparticles. Abalone shell-derived Mg-doped mesoporous hydroxyapatite microsphere drug delivery system loaded with icariin for inducing apoptosis of osteosarcoma cells. Advanced nanoparticles in osteoarthritis treatment. Artificial intelligence-enabled studies on organoid and organoid extracellular vesicles. Corrigendum: Enhanced angiogenesis in porous poly(ε-caprolactone) scaffolds fortified with methacrylated hyaluronic acid hydrogel after subcutaneous transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1